CMS reinstates enforcement discretion under CLIA for certain SARS-CoV-2 tests
During the COVID-19 public health emergency, the Centers for Medicare & Medicaid Services will continue to exercise enforcement discretion under the Clinical Laboratory Improvement Amendments to allow providers to test asymptomatic individuals using certain point-of-care SARS-CoV-2 tests authorized for symptomatic individuals, the Centers for Medicare & Medicaid Services announced Friday. The decision rescinds a Sept. 26 memorandum that ended the 2020 enforcement discretion policy.
Related News Articles
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
The California Department of Public Health Saturday reported the first known case of clade I mpox in the U.S. to the Centers for Disease Control and Prevention…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention Nov. 6 released its annual progress report on health care-associated infections, which showed continued…
Headline
The Centers for Disease Control and Prevention Nov. 1 announced it will host two webinars this week that will address frequently asked questions regarding the…
Headline
The Department of Agriculture Oct. 30 announced the first detection of H5N1 bird flu in a pig. The positive case was found on a farm in Oregon containing a mix…